Topic: regulatory hostility

FDA Rejects Moderna's mRNA Flu Vaccine Application

The FDA rejected Moderna's application for its mRNA flu vaccine, citing concerns over the design of its pivotal clinical trial, which the company claims had received prior agency feedback. The agency specifically questioned the comparator vaccine used in Moderna's large Phase 3 study, even though...